Prostate cancer continues to be a major health issue. The treatment of patients with localised prostate cancer has developed over the last 15 years. Clinicians and patients need a clear understanding of the different treatment options available to allow for fully informed treatment decisions. In this article, we discuss the management of localised prostate cancer referring to the National Institute for Health and Clinical Excellence (NICE) guidance for the disease.